arrow
J

Jordi Bruix

hospital clínic-idibaps
H指数:128
被引数:12.7万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update

用于预后预测和治疗建议的BCLC策略: 2025更新

2025-10-270
PRE
Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association

肝癌患者系统性治疗可及性差异:国际肝病肿瘤协会的分析

2025-07-310
PREAI
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment

《柳叶刀》关于应对全球肝细胞癌负担的委员会报告:从预防到治疗的综合策略

2025-07-280
PRE
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells
2024-04-091
OAAI
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study

肝癌患者合并SARS-CoV-2感染的结局: 一项国际性、多中心、队列研究

2022-06-2310
OAAI